PennantPark Investment Corp. 8-K Summary
Business Context and Reporting Period
This Form 8-K reports on events occurring on March 18, 2014, when PennantPark Investment Corporation held a reconvened annual meeting and a reconvened special meeting of stockholders. The record date for these meetings was December 9, 2013, with 66,546,734 shares of common stock eligible to vote.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance and shareholder voting outcomes.
Material Changes and Voting Results
Two primary matters were submitted to a vote of security holders:
- Director Elections (Annual Meeting): Stockholders elected Marshall Brozost and Samuel L. Katz as Class I directors, serving until the 2017 Annual Meeting.
- Marshall Brozost: 95.39% voted For; 4.61% Withheld.
- Samuel L. Katz: 98.14% voted For; 1.86% Withheld.
- Share Sale Authorization (Special Meeting): Stockholders approved a proposal to authorize the Company to sell shares of common stock at a price below its then-current net asset value (NAV) per share during the next 12 months, subject to Board approval and certain limitations.
- With Affiliates: 81.83% voted For; 17.37% Against; 0.80% Abstain.
- Without Affiliates: 81.28% voted For; 17.89% Against; 0.83% Abstain.
Guidance, Outlook, and Risks
The filing does not contain management commentary on financial outlook, guidance, or specific risk factors beyond the authorization of below-NAV share sales. The approval of the below-NAV sale proposal indicates a strategic decision to provide flexibility in capital raising, which may be relevant to liquidity management but carries the risk of dilution to existing shareholders.
Investor Verification Checklist
- Verify the specific limitations and conditions attached to the below-NAV share sale authorization in the definitive joint proxy statement filed on December 5, 2013.
- Confirm the current Net Asset Value (NAV) per share to assess the potential impact of the newly authorized share sales.
- Review the Company's most recent 10-Q or 10-K for financial performance metrics not included in this 8-K.
- Monitor future filings for any actual issuance of shares under the new authorization.